Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS + Reduced vs Standard Dose Cyclosporine in Elderly Renal Transplant Recipients
NCT00239031Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2002
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Mar 2002; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00239031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239031.